Filana Therapeutics, Inc. (FLNA) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$0.71

From 52W high−72.16%

Volume256696.00

Market cap$32.95M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataOct 19, 2026

Open

$0.71

From 52W high

−72.16%

Volume

256696.00

Market cap

$32.95M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

1.2x

P/E (TTM)

—

RSI (14)

38.7

MomentumView details →

1D Return

−3.06%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

1.2x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

0.5x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−66.47%

ROA (TTM)

−40.69%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

−3.06%

YTD Return

—

1Y Return

—

RSI (14)

38.7

vs 50D SMA

−18.53%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

2.08x

Quick Ratio

2.08x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.18

EPS Surprise

20.00%

Beats (12Q)

1/12

Next Q EPS Est

−$0.27

Avg Surprise (4Q)

20.00%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−42.28M

Op. CF (TTM)

—

Next earningsOct 29, 2026 →

Latest newsMore news →

No recent news for FLNA.

Similar companies

Quince Therapeutics, Inc.QNCX Leap Therapeutics, Inc.LPTX Genenta Science S.p.A.GNTA Quince Therapeutics, Inc.IRLA GridAI Technologies Corp.GRDX CervoMed Inc.CRVO Find similar companies →

Latest newsMore news →

No recent news for FLNA.